| Dear Voornaam,
Welcome to your weekly Cancer Research UK Research Update email.
To mark the start of Childhood Cancer Awareness month, our latest podcast episode features a conversation with Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He has dedicated his career to understanding more about childhood brain tumours and is known for his work identifying different types of medulloblastoma and ependymoma – two of the most common kinds of childhood brain tumour.
Richard talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the transformative discoveries his lab has made on the origins and biology of childhood brain cancers.
|
|
|---|
|
|---|
|
|
September Funding & Research Opportunities |
|
|---|
|
|---|
|
|
October Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
PARTNERSHIP WITH GOSH TO SUPPORT PHDS IN YOUNG PEOPLE’S CANCERS We’ve partnered with Great Ormond Street Hospital Children’s Charity to drive progress in children and young people’s cancers.
The charity will contribute up to £750,000 to support additional PhD studentships at the Cancer Research UK City of London Centre from 2023–27, in research specifically focused on children and young people’s cancers. This additional investment builds on the children and young people’s cancer research theme at the Centre and is an exciting first partnership between our two charities. |
|
|---|
|
|---|
|
|
 ONE WEEK LEFT TO APPLY TO THE CANCER TECH ACCELERATOR Do you have an early-stage innovative idea or technology that can transform the lives of cancer patients?
Cancer Research Horizons’ Cancer Tech Accelerator, in partnership with the MRC, Capital Enterprise and Roche, gives you the opportunity to learn the entrepreneurial and technical skills required to translate your innovations into a start-up in data, MedTech or AI.
For a chance to gain £70,000 of grant funding to enable you to experimentally validate and further de-risk your concept, apply before applications close on 15 September. You don't have to be funded by Cancer Research UK to apply. |
|
|---|
|  PREVENTING CANCER: THE ONLY WAY FORWARD Estimates suggest that by 2040, around 30 million new cancer cases could be expected annually. In The Lancet, the Global Burden of Disease Study collaborators report on their effort to examine the relationship between indicators of metabolic, occupational, environmental, and behavioural risk factors, and cancers globally. The authors found 4.45 million deaths and 105 million disability-adjusted life-years were lost as a result of these risk factors. |
|
|---|
|
|---|
|
|
 DISCOUNTED ENTRY TO THE EARLY DETECTION OF CANCER CONFERENCE Join us for 3 days of stimulating discussions about the latest in early detection research, lightning talks and networking.
Our experts will go head-to-head in our “Great Debates” on the themes of over-diagnosis and multi-cancer early detection tests. Don’t miss Nora Pashayan (University College London), Eithne Costello (University of Liverpool), Paul Limburg (Exact Sciences) and Bob Steele (University of Dundee) for these lively debates.
There’s still time to secure your place at this year’s event in Portland. Use the code UK20EDX to claim 20% off registration. But act soon, discounted places are limited. |
|
|---|
|  LUNG CANCER CONFERENCE APPROACHING We’ve received over 100 abstracts for lightning talks, and we’re still accepting entries for poster presentations. But hurry – submission closes on 9 September.
Join a host of global experts in Manchester on 15–17 November for all the latest in lung cancer research, including Peter Kuhn (USC Michelson), Corrine Faivre-Finn (Cancer Research UK Manchester Institute) and Crispin Hiley (University College London).
Book by 20 September to save with our early bird rate. |
|
|---|
|
|---|
|
|
MOLECULAR ANALYSIS FOR PRECISION ONCOLOGY CONGRESS 2022 Find out what you can expect from this year’s event from Charles Swanton. Discover the latest ground-breaking data in the field of molecular profiling and precision oncology.
Watch the video and follow the link below to register for MAP 2022, live in Amsterdam, and online, on 14–16 October. Discounted registration is available until 21 September. |
|
|---|
|
|---|
|
|
| | | Cambridge, UK 20 September 2022 |
|
|---|
|
|---|
| | | London, UK 10 October 2022 |
|
|---|
|
|---|
| | | Amsterdam, Netherlands 14 October 2022 |
|
|---|
|
|---|
| | | Portland, Oregon, USA 18 October 2022 |
|
|---|
|
|---|
| | | Manchester, UK 15 November 2022 |
|
|---|
|
|---|
| | | East Sussex, UK 04 December 2022 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
